On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayFeb 09, 2018 11:47 am

NetworkNewsBreaks – PotNetwork Holding Inc. (POTN) Sales Drive Optimistic Share Price Target

PotNetwork Holding Inc. (OTC: POTN) has reported favorable monthly sales data and a strong quarterly filing in its drive to produce high-grade CBD for use in oils, tinctures, edibles and vape liquids. This performance is, in turn, generating forecasts for a heightened share price. The holding company for a number of subsidiaries in the hemp-extract medical cannabis industry, PotNetwork has been named 'One of Five Notable CBD Revolution Industry Leaders' by media outlet The Huffington Post. An article discussing this reads: "A recent comprehensive report by SeeThruEquity highlighting PotNetwork Holding Inc. (OTC: POTN) and its subsidiary, Diamond CBD, projected a…

Continue Reading

FridayFeb 09, 2018 9:37 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. Secures Financing Boost for Cannabis Facilities Expansion

Ultra-low cost organic cannabis producer The Green Organic Dutchman Holdings Ltd., also known as TGOD, has benefited from strategic investments by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) and other private placement financing, with its total financing climbing to $160 million. The Aurora investment in TGOD is accompanied by a supply agreement providing Aurora the right to purchase up to 20 percent of TGOD’s annual production of organic cannabis, and TGOD will receive additional services from Aurora and its subsidiary, Aurora Larssen Projects Inc. ("ALPS"). An article discussing this reads: “The investment fully funds the expansion of…

Continue Reading

FridayFeb 09, 2018 9:20 am

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advancing Work on Novel Delivery for Cannabinoid Therapies

A partnership between health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Australia’s UniQuest Pty Limited aimed at furthering research and development of a soluble gel is working toward a novel means of delivering cannabinoids to the central nervous system directly from the nasal cavity in order to treat pain, inflammation, seizures and neurological disorders. The partnership is taking advantage of the growing legalization of medical marijuana throughout the world amid increasing evidence of cannabinoids’ benefits. An article discussing this reads: “The global nasal drug delivery technology market is projected to reach $64 billion by 2021, expanding…

Continue Reading

ThursdayFeb 08, 2018 11:37 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) President Featured in Article Discussing Treasury Secretary’s Recent Cannabis Banking Comments

SinglePoint, Inc. (OTCQB: SING) President Wil Ralston was featured in an article posted earlier this week by Green Market Report examining Treasury Secretary Steve Mnuchin’s recent comments regarding the bankability of the cannabis industry. In an appearance before the House Financial Services Committee related to the Financial Stability Oversight Council’s (FSOC) annual report, Mnuchin stated, “We do want to find a solution to make sure that businesses that have large access to cash have a way to get them into a depository institution for it to be safe.” In response to this comment, Ralston stated, “This is a great step…

Continue Reading

ThursdayFeb 08, 2018 11:03 am

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Unveils Launch Date for Revamped Industrial Hemp CBD Products

Science-based biotechnology company Earth Science Tech, Inc. (OTC: ETST) this morning announced the launch of its revamped industrial hemp cannabidiol (“CBD”) products. Per the update, the company’s highly anticipated High Grade Full Spectrum Cannabinoids – composed of European CO2, supercritical extracted, organically grown and unfiltered industrial hemp – will officially launch on February 13, 2018, alongside a corresponding marketing strategy, as detailed in early December 2017. Upon release of this product line, ETST will become one of the first companies to market its industrial hemp product as a Cannabinoid Complex instead of CBD, disclosing the milligrams of each cannabinoid. “Between…

Continue Reading

ThursdayFeb 08, 2018 10:19 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Pursuing Launch of Cannabis-Focused Cryptocurrency

Payment solutions company Global Payout, Inc. (OTC: GOHE), through majority-owned subsidiary MoneyTrac Technology, Inc. (“MTRAC”), this morning announced that it is completing the final steps and required due diligence for the impending launch of a Regulation D, Rule 506(c) security offering centered around the company’s MTRAC-Token. MTRAC anticipates leveraging this new token as a critical resource for providing banking services throughout the emerging multi-billion dollar cannabis industry. Per the update, the cannabis-focused cryptocurrency is currently on pace to launch by the end of the first quarter of 2018. “The MTRAC-Token is something that I truly believe will be first of…

Continue Reading

ThursdayFeb 08, 2018 9:41 am

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Discovers High Grade Cobalt Assays from Sampling at Cobalt North

Cobalt exploration and development company First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) this morning reported high grade cobalt assays up to 2.01 percent cobalt discovered during surface sampling near the past producing Hamilton mine in Cobalt North. “We are continuing to validate these high grade areas of the Cobalt Camp. Broader mineralized systems with lower average grades are more attractive longer term targets as they hold potential for large low-cost, open pit operations,” Trent Mell, president and CEO of First Cobalt, stated in the news release. “These high grade areas may represent the centre of a broader mineralized system similar…

Continue Reading

WednesdayFeb 07, 2018 3:40 pm

NetworkNewsBreaks – Reign Sapphire Corp. (RGNP) Details Key Features of Sapphire-Backed Cryptocurrency

Direct-to-consumer jewelry company Reign Sapphire Corp. (OTCQB: RGNP) this morning issued an update on some key features of Reign Coin, the company’s sapphire-backed cryptocurrency. These include Reign Coin’s unique sapphire-backed model, which is supported by the company’s own Australian sapphire supply chain; its inventive crypto-dividends, stemming from interest and fees related to the network’s collectively-owned assets; and its groundbreaking growth by transaction business model, through which a portion of all transaction fees are reinvested into sapphires in order to increase the base price and improve the overall solidity of the cryptocurrency. “We are diligently working on this exciting project, and…

Continue Reading

WednesdayFeb 07, 2018 2:30 pm

NetworkNewsBreaks – Experts Predict Another Bull Run for Cryptocurrency Market, $50,000 Price Point for Bitcoin

After the recent big bitcoin fall and rash of digital coin sell-offs—with bitcoin dipping below $6,000 and the overall crypto market losing $550 billion in value on Tuesday—industry insiders are far from discouraged regarding the future of cryptocurrency. On the contrary, experts are predicting a major bull run even bigger than 2017’s, and they are forecasting that cryptocurrencies could surpass a market valuation of $1 trillion this year. "Increasing regulatory recognition of cryptocurrency exchanges, the entrance of institutional capital and major technology developments will contribute to the market's rebound and push cryptocurrency prices to all new highs this year," said…

Continue Reading

WednesdayFeb 07, 2018 2:27 pm

NetworkNewsBreaks – Viking Therapeutics, Inc. (NASDAQ: VKTX) Closes $63.3M Offering

Clinical-stage biopharmaceutical company Viking Therapeutics, Inc. (NASDAQ: VKTX), focused on developing novel therapies for metabolic and endocrine disorders, has announced the closing of an underwritten public offering of 12,650,000 shares of its common stock priced at $5 per share. The offering includes the sale of an additional 1,650,000 shares of common stock pursuant to the full exercises of the over-allotment option granted to the underwriters. A press release regarding the offering states: “The shares were sold at a price of $5.00 per share, resulting in the gross proceeds to Viking Therapeutics of approximately $63.3 Million. Viking Therapeutics currently intends to…

Continue Reading

Contact us: 212.418.1217